Sign In
Buy IRTC
$104.56
-0.94 (-0.89%)
At Close: Jun 03, 2026
PHILADELPHIA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) on behalf of the company's long-term share
iRhythm's Zio ECG System Gets Approval in Japan, Stock Falls
11:55am, Friday, 13'th Sep 2024
IRTC's Zio ECG monitoring system gets approval in Japan, marking a significant step in revolutionizing arrhythmia diagnostics with AI-powered technology.
SAN FRANCISCO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven
iRhythm Stock Gains Following Favorable Zio Monitor Study Data
01:14pm, Tuesday, 10'th Sep 2024
IRTC announces initial findings demonstrating the superior real-world performance of the next-generation Zio LTCM Monitor at the HRX 2024 meeting.
iRhythm Stock May Gain on Its Latest Deal With BioIntelliSense
12:01pm, Monday, 09'th Sep 2024
IRTC announces an exclusive license agreement with BioIntelliSense to develop and commercialize certain patented technology assets within AMC.
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
08:05am, Monday, 09'th Sep 2024
iRhythm's next-generation Zio ® monitor demonstrated longer wear duration and analyzable time compared to the prior generation Zio ® XT device. Longer wear duration and analyzable time may further i
iRhythm Technologies Announces Results of GUARD-AF Trial
01:33pm, Sunday, 01'st Sep 2024
GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024 Leveraging iRhythm's Zio ® patch-based long-term continuous monitoring (LTCM), GUARD-AF is the largest randomize
iRhythm Technologies Launches Zio Monitoring Across Europe
12:21pm, Friday, 30'th Aug 2024
IRTC launches Zio monitor in Austria, Netherlands, Spain and Switzerland, which offers 14-day continuous ECG monitoring, enhancing arrhythmia diagnosis and patient care.
SAN FRANCISCO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent
iRhythm Technologies to Participate in Upcoming Investor Conferences in September
04:05pm, Wednesday, 21'st Aug 2024
SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven
All You Need to Know About iRhythm Technologies (IRTC) Rating Upgrade to Buy
01:00pm, Wednesday, 07'th Aug 2024
iRhythm Technologies (IRTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
iRhythm Technologies, Inc. (IRTC) Q2 2024 Earnings Call Transcript
08:06am, Friday, 02'nd Aug 2024
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q1 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, Investor Relations Quentin Blackford - Presid
IRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
07:15pm, Thursday, 01'st Aug 2024
IRhythm Technologies (IRTC) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.92. This compares to loss of $0.61 per share a year ago.
iRhythm Technologies Announces Chief Financial Officer Transition
04:06pm, Thursday, 01'st Aug 2024
SAN FRANCISCO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc . (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preve
7 Leading MedTech Stocks for Next-Gen Health Solutions
02:30pm, Wednesday, 31'st Jul 2024
While technology lately has been framed in the context of computer hardware or software, it can also apply to the broader field of medicine. Therefore, investors should consider the viable field of Me
